Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

ESSA and Bayer enter clinical collaboration to evaluate EPI-7386 plus darolutamide in mCRPC

April 29, 2021

Pfizer details development of clinical PRMT5 inhibitor candidate PF-06939999

April 29, 2021

Agios Pharmaceuticals and the University of Michigan describe menin/MLL interaction inhibitors

April 29, 2021

Kainos Medicine presents new IRAK-4 inhibitors

April 29, 2021

New Bruton tyrosine kinase inhibitors identified at Newave Pharmaceutical

April 29, 2021

Haihe starts first-in-human study of HH-30134 in advanced solid tumors

April 29, 2021

KRAS G12C inhibitor BI-1823911 shows in vivo efficacy, to enter clinical study

April 28, 2021

Domain Therapeutics discovers PTGER4 antagonists

April 28, 2021

Loss of cell polarity is lung cancer precursor

April 28, 2021

Onconova opens enrollment in phase I study of ON-123300 in advanced cancer

April 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...